EP 1771456 A2 20070411 - HYBRID QA MOLECULES WHEREIN Q IS AN AMINOQUINOLINE AND A IS AN ANTIBIOTIC RESIDUE, THEIR SYNTHESIS AND THEIR USES AS ANTIBACTERIAL AGENT
Title (en)
HYBRID QA MOLECULES WHEREIN Q IS AN AMINOQUINOLINE AND A IS AN ANTIBIOTIC RESIDUE, THEIR SYNTHESIS AND THEIR USES AS ANTIBACTERIAL AGENT
Title (de)
HYBRIDE QA-MOLEKÜLE, IN DENEN Q EIN AMINOCHINOLIN UND A EIN ANTIBIOTIKARÜCKSTAND IST, IHRE SYNTHESE UND IHRE VERWENDUNG ALS ANTIBAKTERIELLES MITTEL
Title (fr)
MOLECULES HYBRIDES QA OU Q EST UNE AMINOQUINOLEINE ET A EST UN RESIDU ANTIBIOTIQUE, LEUR SYNTHESE ET LEURS UTILISATIONS EN TANT QU'AGENT ANTIBACTERIEN
Publication
Application
Priority
- FR 2005001937 W 20050726
- FR 0408441 A 20040730
- US 1945004 A 20041223
Abstract (en)
[origin: WO2006024741A2] The invention concerns an aminoquinoline-antibiotic hybrid compound of general formula (I): Q-(Y<SUB>1</SUB>)<SUB>p</SUB>-(U)<SUB>p'</SUB>-(Y<SUB>2</SUB>)<SUB>p''</SUB>-A; wherein Q represents an aminoquinoline, (Y<SUB>1</SUB>)<SUB>p</SUB>-(U)<SUB>p'</SUB>-(Y<SUB>2</SUB>)<SUB>p''</SUB> is an optional spacer and A is an antibiotic residue. The invention enables the antibiotic residue activity to be unexpectedly enhanced.
IPC 8 full level
C07D 499/76 (2006.01); A61K 31/4709 (2006.01); A61P 31/04 (2006.01); C07D 215/56 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 499/48 (2006.01); C07D 499/54 (2006.01); C07D 499/64 (2006.01); C07D 501/00 (2006.01); C07D 501/34 (2006.01); C07K 5/00 (2006.01)
CPC (source: EP US)
A61P 1/00 (2017.12 - EP); A61P 1/02 (2017.12 - EP); A61P 1/16 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 27/16 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 215/56 (2013.01 - EP US); C07D 401/12 (2013.01 - EP US); C07D 413/12 (2013.01 - EP US); C07D 499/00 (2013.01 - EP US); C07D 501/00 (2013.01 - EP US); C07K 5/06139 (2013.01 - EP US); C07K 7/06 (2013.01 - EP US); C07K 7/08 (2013.01 - EP US); C07K 9/008 (2013.01 - EP US)
Citation (search report)
See references of WO 2006024741A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006024741 A2 20060309; WO 2006024741 A3 20060622; AU 2005279050 A1 20060309; BR PI0514381 A 20080610; CA 2572442 A1 20060309; EP 1771456 A2 20070411; JP 2008508243 A 20080321; NO 20070725 L 20070416; US 2007060558 A1 20070315
DOCDB simple family (application)
FR 2005001937 W 20050726; AU 2005279050 A 20050726; BR PI0514381 A 20050726; CA 2572442 A 20050726; EP 05793347 A 20050726; JP 2007523114 A 20050726; NO 20070725 A 20070208; US 51669206 A 20060907